ARTICLE | Company News
Lexicon, Xoma antibody deal
June 22, 2005 1:54 AM UTC
LEXG and XOMA partnered to develop antibodies against targets provided by LEXG. LEXG will select targets from its Genome5000 program, and XOMA will generate or engineer the antibodies using its phage ...